Kevin Ali

2021

In 2021, Kevin Ali earned a total compensation of $16.8M as Chief Executive Officer at Organon & Co..

Compensation breakdown

Non-Equity Incentive Plan$1,487,063
Option Awards$5,979,437
Salary$1,134,451
Stock Awards$7,731,558
Other$455,114
Total$16,787,623

Ali received $7.7M in stock awards, accounting for 46% of the total pay in 2021.

Ali also received $1.5M in non-equity incentive plan, $6M in option awards, $1.1M in salary and $455.1K in other compensation.

Rankings

In 2021, Kevin Ali's compensation ranked 440th out of 12,406 executives tracked by ExecPay. In other words, Ali earned more than 96.5% of executives.

ClassificationRankingPercentile
All
440
out of 12,406
97th
Division
Manufacturing
139
out of 5,494
98th
Major group
Chemicals And Allied Products
43
out of 2,369
98th
Industry group
Drugs
38
out of 2,090
98th
Industry
Pharmaceutical Preparations
22
out of 1,537
99th
Source: SEC filing on April 28, 2022.

Ali's colleagues

We found four more compensation records of executives who worked with Kevin Ali at Organon & Co. in 2021.

2021

Matthew Walsh

Organon & Co.

Chief Financial Officer

2021

Susanne Fiedler

Organon & Co.

EVP and Chief Commercial Officer

2021

Deborah Telman

Organon & Co.

General Counsel

2021

Sandra Milligan

Organon & Co.

EVP and Head of Research & Development

News

You may also like